Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
01/2004
01/02/2004EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
01/02/2004EP1373252A1 Chemical derivatives and their use as anti-telomerase agent
01/01/2004US20040002513 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/2003
12/31/2003WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
12/31/2003WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/25/2003US20030236279 Central nervous system disorders; psychological disorders
12/25/2003US20030236270 Central nervous system disorders
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/24/2003WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase
12/24/2003WO2002100858A8 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
12/24/2003WO2002085901A8 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/18/2003WO2003104227A1 2-heteroaryl carboxamides
12/18/2003WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
12/18/2003US20030232853 Azabicyclic compounds for the treatment of disease
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003024926A3 Methods and compositions of novel triazine compounds
12/11/2003WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/09/2003US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003070728A3 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
12/04/2003US20030225094 E.g, 4-(2-((6R,12aR)-6-benzo(1,3)dioxol-5-yl-1,4-dioxo -3,4,6,7,12,12a-hexahydro-1H-pyrazino-(1',2':1,6)pyrido(3,4-b) indol-2-yl)ethyl)-benzenesulfonamide; inhibitors of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase
12/03/2003EP1366049A2 Pirazino[1'2':1,6]pyrido[3,4-b]indole derivatives
11/2003
11/27/2003US20030220298 Combrestatin a-1 phosphate and combrestatin b-1 phosphate prodrugs
11/26/2003EP1363612A2 Peptide deformylase inhibitors
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/19/2003EP1361871A2 Medicament formulation containing a muscarinic agonist
11/19/2003EP0984970B1 Spiro-quinuclidine derivatives, their preparation and use
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003053966A3 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
11/13/2003US20030212292 Shortened synthesis of 3,3-diarylpropylamine derivatives
11/13/2003US20030212098 Optically active isomers of quinine and quinidine and their respective biological action
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/11/2003US6646135 Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/06/2003WO2003091207A2 Method of preparing amine stereoisomers
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003US20030207913 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
11/06/2003CA2482432A1 Method of preparing amine stereoisomers
11/04/2003US6642246 Quinuclidine acrylamides
10/2003
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003US20030204112 Hydrogenation of prochiral ketones
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/29/2003EP1355873A1 Pleuromutilin derivatives with antimicrobial activity
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087104A1 Heterocyclic compounds
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003CA2482313A1 Heterocyclic compounds
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/22/2003EP1354883A1 Hydrogenation of prochiral ketones
10/22/2003EP1353919A2 Novel quinuclidine derivatives and medicinal compositions containing the same
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/15/2003EP1352906A1 Compositions for prevention or treatment of hepatopathy
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351957A1 Chemical derivatives and their use as anti-telomerase agent
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1051374B1 The use of compressed carbon dioxide in chemical reactions
10/15/2003CN1449396A Carbamates derived from arylalkylamines
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
09/2003
09/25/2003WO2003078431A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
09/25/2003WO2003078430A1 Amides of acetic and propionic acids
09/25/2003US20030181474 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/24/2003EP1345937A1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP0840735B1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl]
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/23/2003US6624173 Pharmaceutical compositions for treating and/or preventing CNS disorders
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003US20030176702 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/17/2003EP0910566B1 Heterocyclic compounds and their preparation and use
09/16/2003US6620945 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents
09/16/2003US6620824 Process for the synthesis of gonadotropin releasing hormone antagonists
09/12/2003WO2003045940A3 Benzazepine derivatives and their use as 5-ht ligands
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 58